Around the Corner: Digital Health Post-Pandemic Webinar Series

WEBINAR 1: The future of telehealth after covid-19

Prior to the pandemic, health providers and stakeholders were quickly moving to develop and expand existing telehealth programs. Now we are seeing an adoption of telehealth solutions that far surpasses all of the activity we saw in the past five years combined. Telehealth is the new normal and there is no turning back. Patients and providers will continue to engage with one another virtually after COVID-19, but what this engagement looks like depends on a multiplicity of factors. We spoke with industry leaders from a number of sectors to learn how they and their organizations are moving forward to deliver care and services in a new world.

SPEAKERS

• Andre Blom, CEO, Illinois Bone & Joint Institute
• Henry Bennett, General Counsel, Babylon Health
• Jay Parkinson, MD, MPH, Chief Designer, Crossover Health
• Jennifer Geetter, Partner, McDermott Will & Emery
• Lisa Schmitz Mazur, Partner, McDermott Will & Emery
• Jim Watson, Principal, Healthcare Advisory, BDO

WEBINAR 2: Digital Delivery of Healthcare Services After COVID-19

The pandemic has underscored the urgency for developing, deploying and leveraging innovative digital tools and has likely increased provider, patient and consumer comfort in using technologies to help manage and inform healthcare delivery. Looking ahead, we anticipate an acceleration of remote monitoring, clinical decision support software, and patient engagement apps and tools that move beyond an episodic care delivery model to an enhanced continuum of care. We spoke with Livongo, Cricket, and BehaVR for a detailed discussion about the future of digital delivery of healthcare services after COVID-19, including:

• Information integration: Building a successful ecosystem of healthcare partners
• Moving beyond initial decision-making: How to use these tools for ongoing care management
• Patient experience: How to onboard patients and solving pitfalls of patient engagement
• Role of AI
• Data governance: Data discipline, privacy/security, data strategies, IP and de-identification
• Liability and risk management

SPEAKERS

• Moderator:  Jennifer S. Geetter, Partner, McDermott
• Arvind Rajan, Co-Founder & CEO, Cricket Health
• Amar Kendale, Chief Product Officer, Livongo
• Aaron Gani, Founder, BehaVR
• Sandra M. DiVarco, Partner, McDermott

WEBINAR 3: Preparing Your Data for a Post-COVID-19 World

The COVID-19 pandemic highlighted the weaknesses of the US healthcare system’s data infrastructure. While efforts by government and industry to enhance data standards and multi-party connectivity had gathered momentum pre-COVID-19, efforts have slowed during the public health emergency, when data sharing and accessibility are needed more than ever. Joined by Validic and Arcadia, we discussed key elements of the US healthcare system’s data infrastructure, as well as actions needed to prepare for future health crises, streamline patient care, improve consumer care access and move toward the delivery of coordinated care, including:

• Review of interoperability and application programming interfaces (API) readiness planning
• Consumer-to-provider communications via standardized APIs
• Provider–to-provider communications via event notification services and other vehicles
• Provider–to-government communications to support public health and disease prevention

SPEAKERS

• Moderator & Program Leader: Stephen W. Bernstein, Partner, McDermott Will & Emery
• Micky Tripathi, PhD, MPP, Chief Alliance Officer, Arcadia
• Drew Schiller, Co-Founder and CEO, Validic
• Scott A. Weinstein, Partner, McDermott Will & Emery
• Bernadette M. Broccolo, Partner, McDermott Will & Emery

WEBINAR 4: Digital Health at Scale: The Payor Perspective

The COVID-19 pandemic has catalyzed efforts by health insurers to expand reimbursement for telehealth services and digital health tools, and develop and invest in their own digital health tools. Health insurers, who increasingly play a hybrid role of payor, innovator and provider, have a vested interest in helping consumers manage chronic diseases and engage in preventive care from home, both during the public health emergency and after. We explored the role of health insurers in the evolving digital health market with Humana, Oscar Health and Medorion, including:

• Pre-pandemic efforts to integrate digital health capabilities into the traditional health insurance framework
• How the COVID-19 pandemic has impacted coverage for telehealth and digital health tools
• Digital member engagement before, during and after COVID-19
• Reimbursement pathways and laws impacting reimbursement
• Unique health insurer partnerships and investments in technology
• The outlook for 2021 and beyond

SPEAKERS

• Moderator: Kate McDonald, Partner, McDermott Will & Emery
• Hank Greenberg, General Counsel, Oscar Health
• Asaf Kleinbort, CEO / Co-Founder, Medorion
• Elysia Solomon, Deputy General Counsel and Senior VP, Clinical, Technology and Privacy Legal Team, Humana Inc.
• Marshall E. Jackson, Jr., Partner, McDermott Will & Emery

WEBINAR 5: Evolving Opportunities and Challenges for Real-World Evidence and Data-Powered Solutions

Healthcare research has faced severe disruption during the COVID-19 public health emergency and underscored the need for novel technological solutions that harness and utilize data beyond traditional clinical research models. From real-world evidence (RWE) and real-world data (RWD) to registries, predictive analytics and virtual clinical trials, solutions that combine data, powerful computing and novel data collection methods can present healthcare innovators, researchers and drug and device developers with robust, actionable insights to transform care and develop cutting-edge products and therapeutics. We spoke with Aetion and CancerLinQ, a non-profit subsidiary of the American Society of Clinical Oncology (ASCO), and explored the legal and operational considerations of RWE, RWD and other data-powered solutions, including:

• How can care providers and researchers optimally collect new data and evidence through virtual means and in ways that maximize utility for generating regulatory-grade RWE and other applications downstream?
• How can researchers and providers collaborate with technology companies to leverage RWE and RWD for regulatory decision-making?
• What are the Food and Drug Administration regulatory considerations, privacy considerations and use cases under different privacy pathways presented by large-scale data collection and digital data use?
• How can old and new stakeholders contribute to the digital data paradigm and tap into unrepresented groups and other sources of data?
• What is the pandemic’s short- and long-term impact on the demand for alternative sources of data and what challenges exist to procuring these data sources?

SPEAKERS

• Carolyn Magill, CEO, Aetion
• George Komatsoulis, PhD, Chief of Bioinformatics, CancerLinQ a non-profit subsidiary of ASCO
• Stephen W. Bernstein, Partner, McDermott Will & Emery
• Jiayan Chen, Partner, McDermott Will & Emery
• Jennifer S. Geetter, Partner, McDermott Will & Emery
• Anisa Mohanty, Associate, McDermott Will & Emery